Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?
about
Pancreatic endocrine neoplasms: a current update on genetics and imaging.Reinventing diagnostics for personalized therapy in oncologySystematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs).Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines.Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution.Current and future systemic treatment options in metastatic pancreatic cancer.Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasTumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Surgical treatment and clinical outcome of nonfunctional pancreatic neuroendocrine tumors: a 14-year experience from one single center.Cytoplasmic Clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage.RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasmsAdjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resectionClinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas.Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution.Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.A simplified prognostic system for resected pancreatic neuroendocrine neoplasms.Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndromePancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.Validation of five contemporary prognostication systems for primary pancreatic endocrine neoplasms: results from a single institution experience with 61 surgically treated cases.Surgical management of pancreatic neuroendocrine tumors.Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.Prognostic markers in smear preparations for pancreatic endocrine neoplasms: A cytomorphologic study and statistical analysis of 20 potential prognostic features.Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia.Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
P2860
Q26852418-B81E20A3-0120-48D9-AC70-2900BD3AE9C0Q28391395-0E1D8BBD-7DD9-4754-B1D3-E4085C0EB64AQ30244079-DDAD3D92-9453-431D-AFF8-91CC31C5B4BDQ30410852-2053F1A3-1790-45B3-9591-599722076F81Q33597784-E5222413-6911-4C79-889F-44E2FAED224AQ33782024-E69EF1CE-C209-402D-ADB4-3CE627D5D65AQ33892438-6E722F48-A0B2-4052-9337-64772DDABAB2Q33948033-8CC8FE80-7D9C-4C2C-B504-447041D5DD12Q34182397-45702A85-24AB-4296-8A63-5FCD6289A53EQ34248466-493DBAFA-7BD9-4329-BB06-0E9FA1E3E2D3Q34413108-46BEE840-0FFA-4D1C-B660-EDD26CDF9B3DQ34652902-BF7858B2-AD3C-443C-8469-7D0565C3318EQ35001777-2D420B4D-1E2A-4697-9386-BAF2EA935284Q35034000-05C6DD87-98FF-41D8-AD0C-175DD834BD3EQ35074944-211631EF-83E3-4D13-A609-A988FD119B1AQ35760798-AC561FC9-789B-47EA-BA31-04A20481EEF3Q36193534-3A0A1CD3-9572-4A31-AD74-5A069E2B12DDQ36280303-9A3FE1D6-0BBA-46A4-A456-9EC0FC2164F4Q36518549-EA59DA39-9950-4592-AF6A-D8215309C04EQ36609360-C5348CA3-5995-45FA-AC00-313E2A5D14A0Q36831573-9F6CBED2-D1A9-485C-ACD6-8261734DAFE5Q36843996-61B14EB6-37C8-4D42-A135-6B754C2D9FB4Q36879154-11EAA9F8-D765-44D2-81D8-BB30B0420342Q37116888-5925C40A-B7A2-40E6-A9DF-7CB160F90491Q37182620-247AF61A-CD9A-4929-941E-72E4B3B1EF5EQ37343429-B8E1C769-C002-4422-AD18-D7D2CB12705EQ37497667-86DF4ECE-1469-4110-B4CE-2536E02532D0Q37669053-EF345993-02D9-4051-B5F6-00F30C8FCBECQ37837078-BA07F8AA-6BD9-408B-9FB3-E5098B51D0AEQ37933151-48AA4E03-4AF6-4947-A912-A46CC671A889Q38052101-2955C89E-8631-4EDA-8346-BD7B28ABAF22Q38853033-18D33252-D7E2-4B39-9FF1-C197FFA5D2A5Q39159369-9ED14C66-7AF6-44D1-9428-4774EC96E2D5Q39271421-EE0270F7-83C7-4E73-B07D-F6D29D193549Q39301100-ADC0943B-7345-41D1-BD91-7C8CEFB72F0CQ39451576-6CDDED6D-C040-4CD0-8C83-97BB1C9BA284Q40206906-28FE4F66-0F3E-42C1-8C3F-75E65E6EDCC2Q40288265-B6C06619-717F-4FFC-AEA3-24F4BACAC21EQ40686883-195FA647-4E76-4C00-A21D-A691E6320C47Q41031563-25F3718C-8EA4-4B6E-8194-4A2BCB0715AF
P2860
Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?
description
im Dezember 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2007
@uk
name
Determining Prognosis in Patie ...... fication System Be Simplified?
@en
Determining Prognosis in Patie ...... fication System Be Simplified?
@nl
type
label
Determining Prognosis in Patie ...... fication System Be Simplified?
@en
Determining Prognosis in Patie ...... fication System Be Simplified?
@nl
prefLabel
Determining Prognosis in Patie ...... fication System Be Simplified?
@en
Determining Prognosis in Patie ...... fication System Be Simplified?
@nl
P2093
P356
P1476
Determining prognosis in patie ...... fication system be simplified?
@en
P2093
Cristina R Ferrone
David S Klimstra
James Tomlinson
Laura H Tang
Mithat Gonen
Peter J Allen
Steven N Hochwald
P304
P356
10.1200/JCO.2007.12.9809
P407
P577
2007-12-01T00:00:00Z